Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Circ Cardiovasc Interv. 2021 Oct 22;14(11):e011028. doi: 10.1161/CIRCINTERVENTIONS.121.011028

Table 6:

BA-Lampoon Procedural Characteristics and Outcomes

Procedural Characteristics N = 4
Access 4 (100%) Transfemoral/trans-septal
Sentinel cerebral protection 3 (75%)
General anesthesia 4 (100%)
Apical rail 2 (50%)
Procedural Outcomes
Successful traversal 4 (100%)
Midline/lengthwise laceration 4 (100%)
Time added by BA, min 11.5 ± 4.4
New or increase pressor Use 4 (100%)
Prophylactic IABP 3 (75%)
Successful TMVR implant 4 (100%)
Need for second valve 0
Required bail-out ASA 0
LVOT obstruction 0
Pericardial effusion requiring drainage 2 (50%)
Paravalvular leak > mild 1 (25%) planned AVP during index procedure
MR > mild 0
Procedural Complications
Stroke 0
Major vascular complication 0
Life threatening bleed 0
Echocardiographic Outcomes
Ejection fraction 53% ± 5.0
MV mean gradient, mmHg 5.3 ± 1.5
MR severity > mild 0
Perivalvular MR > mild 1 (25%)
LVOT gradient, mmHg 9.8 ± 5.0
LVOT gradient increase < 10 mmHg 3 (75%)
AV mean gradient, mmHg 15.3 ± 9.5
Survival
Survived procedure 4 (100%)
Survived to 30 days 3 (75%)

A table summarizing procedural, echocardiographic and clinical outcomes data from all BA-LAMPOON patients.

Abbreviations: ASA – alcohol septal ablation, AV – aortic valve, ASA – alcohol septal ablation, AVP – Amplatzer vascular plug, BA – balloon-augmented, IABP – intra-aortic balloon pump, LVEF – left ventricular ejection fraction, LVOT – left ventricular outflow tract